🔬 Breakthrough for late-stage Hodgkin lymphoma: NICE has approved brentuximab vedotin combination therapy as the first treatment specifically for previously untreated stage 3 or 4 classical Hodgkin lymphoma.
This could benefit 800 patients per year.
https://t.co/IqCwsh73nZ
@DeeptiRadia presenting update on Avapritinib from the PATHFINDER study. Excellent timing given that Avapritinib has been approved for AdvSM patients in the UK 🥳 #mastocytosis#mpnsm
Patients with blood cancers are more vulnerable to the COVID-19 virus than those with solid tumours, according to a major analysis. https://t.co/SmRazlNTYu
Our vehicles are 7 seater, 4x4, full leather interior with panoramic sunroof ensuring you a comfortable journey to whichever tour destinations you choose. Enjoy your Hebridean experience in luxury. Visit link in our bio & call now to book 👍 @OuterHebs@VisitScotland#Hebrides